These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12431980)

  • 21. Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics.
    Blum G; Gazit A; Levitzki A
    J Biol Chem; 2003 Oct; 278(42):40442-54. PubMed ID: 12869569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of insulin-like growth factor 1 receptor participates downstream of GPR30 in estradiol-17β-D-glucuronide-induced cholestasis in rats.
    Barosso IR; Miszczuk GS; Ciriaci N; Andermatten RB; Maidagan PM; Razori V; Taborda DR; Roma MG; Crocenzi FA; Sánchez Pozzi EJ
    Arch Toxicol; 2018 Feb; 92(2):729-744. PubMed ID: 29090346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.
    Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
    Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
    Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.
    Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E
    Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
    Wood ER; Shewchuk L; Hassel A; Nichols J; Truesdale AT; Smith D; Carter HL; Weaver K; Barrett G; Leesnitzer T; Alvarez E; Bardera AI; Alamillo A; Cantizani J; Martin J; Smith GK; Jensen DE; Xie H; Mook R; Kumar R; Kuntz K
    Biochem Pharmacol; 2009 Dec; 78(12):1438-47. PubMed ID: 19665448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
    Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
    Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
    Buck E; Gokhale PC; Koujak S; Brown E; Eyzaguirre A; Tao N; Rosenfeld-Franklin M; Lerner L; Chiu MI; Wild R; Epstein D; Pachter JA; Miglarese MR
    Mol Cancer Ther; 2010 Oct; 9(10):2652-64. PubMed ID: 20924128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells.
    Kuribayashi A; Kataoka K; Kurabayashi T; Miura M
    Endocrinology; 2004 Nov; 145(11):4976-84. PubMed ID: 15271882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
    Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA
    Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
    Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
    Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.
    Zovko A; Novak M; Hååg P; Kovalerchick D; Holmlund T; Färnegårdh K; Ilan M; Carmeli S; Lewensohn R; Viktorsson K
    Oncotarget; 2016 Aug; 7(31):50258-50276. PubMed ID: 27384680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
    Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
    Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells.
    Boney CM; Sekimoto H; Gruppuso PA; Frackelton AR
    Cell Growth Differ; 2001 Jul; 12(7):379-86. PubMed ID: 11457735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
    Kim EJ; Shin HK; Park JH
    J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
    Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
    Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.